Anti-malaria drug hydroxychloroquine’s coronavirus trials to resume, says WHO

Anti-malaria drug hydroxychloroquine will be once again tested for its effectiveness against the novel coronavirus as the World Health Organization has decided to resume its trials under the Solidarity Trials.